Mycobacterial infections, particularly tuberculosis (TB) and leprosy, continue to pose significant global health challenges. While first-line treatments are effective for many, the emergence of drug-resistant strains necessitates a robust arsenal of therapeutic agents. Among these, Ethionamide (CAS 536-33-4) stands out as a vital component in specific treatment regimens. As a dedicated pharmaceutical intermediate supplier, understanding the significance and applications of Ethionamide is paramount for researchers and procurement managers in the pharmaceutical sector.

Ethionamide is a synthetic thioamide derivative that plays a crucial role in the fight against mycobacteria. It is primarily utilized in combination with other anti-tuberculosis drugs for patients who have not responded to standard first-line treatments. Its mechanism of action involves inhibiting the synthesis of mycolic acids, essential components of the mycobacterial cell wall. This disruption ultimately compromises the integrity and viability of the bacteria. Beyond TB, Ethionamide is also employed in the treatment of leprosy, often as part of a multi-drug therapy approach.

For professionals seeking to buy Ethionamide CAS 536-33-4, sourcing from a reputable manufacturer in China ensures both quality and cost-effectiveness. Our commitment as a leading Ethionamide supplier is to provide a high-purity product (≥99% assay), meeting the stringent demands of pharmaceutical applications. We understand that consistent quality and reliable supply are non-negotiable for our clients in the pharmaceutical industry.

When considering the Ethionamide price, it's important to evaluate the overall value proposition, which includes not only the cost per kilogram but also the assurance of quality, compliance with standards (such as USP, BP, EP), and the stability of the supply chain. Investing in a trusted partner for your Ethionamide procurement means securing a critical raw material that directly impacts the efficacy of life-saving treatments.

The therapeutic applications of Ethionamide extend to other challenging mycobacterial infections, such as those caused by non-tuberculous mycobacteria. Its broad-spectrum activity against certain mycobacterial species underscores its importance in various clinical scenarios. For research purposes, Ethionamide also serves as a valuable tool for studying drug resistance mechanisms and developing new therapeutic strategies.

In conclusion, Ethionamide remains an indispensable agent in the global health landscape. For procurement managers and R&D scientists, identifying a dependable Ethionamide manufacturer that offers consistent quality and competitive pricing is key. By partnering with a leading supplier, you can ensure the availability of this critical pharmaceutical intermediate for your formulation and research needs.